Skip to main content
Caplight Logo









Opna Bio

Opna Bio

Private
South San Francisco, CaliforniaHealthcare & Life Scienceshttps://opnabio.com

Last Round

Series A

Nov 21, 2022

Total Funding Raised

$38M

Company Overview

Opna Bio operates in Healthcare & Life Sciences and is based in South San Francisco, California. Its latest recorded funding round was a Series A round in November 2022.

Opna Bio is a clinical-stage biopharmaceutical company that discovers and develops novel oncology therapeutics targeting immune suppression and other hallmarks of cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Opna Bio Comparables

Compare Opna Bio with similar companies based on industry and business-model similarity.

Opna Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CellCentric
84%
C4 Therapeutics
76%
Novartis
75%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Opna Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ANov 21, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Opna Bio Investors

Notable investors and investment history

Opna Bio investors
InvestorRounds
Longitude CapitalSeries A
Northpond VenturesSeries A
Menlo VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 22, 2025

    Added ByPost, a logistics/shipping SMB, as a customer.

  • Nov 22, 2025

    Added Twinhub (Pvt) Ltd. from IT Services and IT Consulting.

Book a demo to see all signals

For institutional investors. Book with your work email.

Opna Bio Filings

Explore SEC and related filing metadata, where available.

Opna Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Opna Bio's valuation, stock price, and market status.

Is Opna Bio a public or private company?

Opna Bio is a private company.

What is the current stock price of Opna Bio?

Opna Bio is a private company, so its shares have no public market price. Caplight tracks Opna Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Opna Bio worth (valuation)?

Valuation information for Opna Bio is not publicly available.

Can I buy Opna Bio stock?

Opna Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Opna Bio's last funding round?

Opna Bio's most recent funding round was Series A on November 21, 2022.

Who are the main investors in Opna Bio?

Key investors in Opna Bio include Longitude Capital, Northpond Ventures.

Will Opna Bio IPO soon?

No public IPO plans have been announced for Opna Bio.

How can I track Opna Bio secondary market activity?

Caplight tracks bids, offers, and trades in Opna Bio's shares on secondary markets.

Firmographic Details

HeadquartersSouth San Francisco, California
Employee Range21
Year Founded2022
Last FundingNov 21, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?